- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03056716
Silastic Versus Conventional Drain in Thoracic Surgery (SD-CD)
February 16, 2017 updated by: Serhat Yalcinkaya,MD, T.C. Dumlupınar Üniversitesi
Silastic Versus Conventional Drain for Postoperative Drainage in Thoracic Surgery.
In thoracic surgery, it is usual to place apical and basal drains for complete drainage of air and fluid out of the pleural cavity.
The routinely used drains are mainly made of plastic.
Recently silastic drains of smaller size are used without any complication.
The investigators designed a prospective randomized trial to compare the draining properties of the two types of drains following various resections in thoracic surgery.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
Following the Institutional Review Board permission (permission no: 2009/27) the investigators started to recruit patients for the study in June 2009.
Pneumonectomy, decortication, and diaphragm plication patients were not included in this study.
The patients were consecutively placed in one of the two groups.
In Group I, an apical 28FR size CD, and a basal 19FR SD were placed following surgery.
In Group II, the apical drain was 28FR, and the basal drain was 32FR CDs.
Basal drains were removed out when daily serous fluid drainage became 200 ml or less, and the apical were removed 48-72 hours following the cessation of air leak.
The patients were discharged on the day after drain removal.
The data concerning gender, age, diagnosis, operation side, type of operation, amount of fluid drainage, duration of fluid and air drainage, length of hospital stay, and complications if any, were noted.
Study Type
Interventional
Enrollment (Actual)
118
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Yildirim
-
Bursa, Yildirim, Turkey, 16330
- Bursa Yuksek Ihtisas Research and Education Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
14 years and older (Child, Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Candidates of surgery willing to participate in the experimental arm of the study and signing the informed consent form.
Exclusion Criteria:
- Pneumonectomy, diaphragm plication, and decortication candidates
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Silastic drain
Placement of 19FR silastic drain as basal drain
|
Apical drains will be identical in size and material, and the basal drains will be different in groups.
The patients will be followed for daily amounts of fluid drainage, duration of air leaks and fluid drainage, and duration of hospitalization, and the results will be compared statistically to asses any possible relationships with the outcome and the type of basal drain used.
|
Active Comparator: Conventional drain
Placement of 32FR conventional drain as basal drain
|
Apical drains will be identical in size and material, and the basal drains will be different in groups.
The patients will be followed for daily amounts of fluid drainage, duration of air leaks and fluid drainage, and duration of hospitalization, and the results will be compared statistically to asses any possible relationships with the outcome and the type of basal drain used.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Duration of hospital stay
Time Frame: 3 years
|
Duration of hospital stay will be noted on the study datasheet and will be measured in days.
|
3 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Daily amount of fluid drainage
Time Frame: 3 years
|
Daily amount of fluid drainage will be measured in mililiters during the daily rounds everyday, and will be noted on the datasheet.
|
3 years
|
Duration of fluid drainage
Time Frame: 3 years
|
Everyday the drains will be checked for fluid drainage and the day without any drainage will be noted on the datasheet.
Duration of fluid drainage will be measured in days since the postoperative day 1.
|
3 years
|
Duration of air leak
Time Frame: 3 years
|
Everyday the drains will be checked for air leaks and the day without any air leak will be noted on the datasheet.
Duration of air leak will be measured in days since the postoperative day 1.
|
3 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 1, 2009
Primary Completion (Actual)
June 1, 2012
Study Completion (Actual)
December 1, 2012
Study Registration Dates
First Submitted
February 7, 2017
First Submitted That Met QC Criteria
February 14, 2017
First Posted (Actual)
February 17, 2017
Study Record Updates
Last Update Posted (Actual)
February 20, 2017
Last Update Submitted That Met QC Criteria
February 16, 2017
Last Verified
February 1, 2017
More Information
Terms related to this study
Other Study ID Numbers
- Silastic vs conventional drain
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Yes
IPD Plan Description
Patient data except for the names and ID numbers will be shared.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Air Leak From Lung
-
Baxter Healthcare CorporationCompletedAir Leak From LungItaly, Spain
-
Centre hospitalier de l'Université de Montréal...Recruiting
-
Boston Medical CenterGunze LimitedWithdrawnAir Leak From LungUnited States
-
Lawson Health Research InstituteNot yet recruiting
-
Centre hospitalier de l'Université de Montréal...Recruiting
-
Kerckhoff KlinikCompleted
-
University Hospital, Basel, SwitzerlandCompletedProlonged Air Leak | Postoperative Air LeakSwitzerland
-
Fundación Instituto de Estudios de Ciencias de...Baxter Healthcare Corporation; Instituto de Investigación Biomédica de SalamancaCompletedProlonged Air Leak | Lung ResectionSpain
-
Centese, Inc.NYU Langone HealthCompletedPulmonary Air LeakUnited States
-
Ottawa Hospital Research InstituteCompletedPulmonary Air LeakCanada
Clinical Trials on Silastic vs conventional drain in thoracic surgery
-
Joseph D. TobiasCompletedOne-lung Ventilation (OLV)United States
-
Kantonsspital LiestalCompletedPostoperative Nausea and VomitingSwitzerland
-
Institut Paoli-CalmettesCompletedUTERINE CERVICAL NEOPLASMS | ENDOMETRIAL NEOPLASMSFrance
-
Hippocration General HospitalCompletedCoronary Artery Disease | Atherosclerosis | Endothelial Dysfunction | Oxidative Stress | HMG-CoA Reductase Inhibitor ToxicityGreece
-
Haukeland University HospitalCompleted
-
Roswell Park Cancer InstituteCompleted
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedIntraocular MelanomaUnited States
-
Direct TherapeuticsUnknownBrain and Central Nervous System Tumors | Metastatic CancerUnited States
-
Direct TherapeuticsUnknownBrain and Central Nervous System TumorsUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedColorectal Cancer | Neoplasm of Uncertain Malignant PotentialUnited States